UnitedHealth Group stands out as a solid investment choice amidst financial uncertainty. With an equity beta of 0.67, it offers a stable investment with growth potential. The company, driven by ...

U.S. drugmakers Johnson & Johnson and Eli Lilly increased spending on security for their top executives in 2024, citing ...

We recently compiled a list of the 10 Best Low Risk Stocks To Buy in 2025. In this article, we are going to take a look at ...

We recently compiled a list of the Top 10 Health Insurance Stocks To Buy. In this article, we are going to take a look at ...

In the latest trading session, UnitedHealth Group (UNH) closed at $486.04, marking a +1.21% move from the previous day.

Stock analysts at Zacks Research upped their Q1 2026 earnings estimates for shares of UnitedHealth Group in a research report ...

Representative Jefferson Shreve (R-Indiana) recently sold shares of UnitedHealth Group Incorporated (NYSE:UNH). In a filing disclosed on March 09th, the Representative disclosed that they had sold ...

RiverPark Advisors, an investment advisory firm and sponsor of the RiverPark family of mutual funds, released its “RiverPark ...

UnitedHealth acquired or created 250 subsidiaries in 2024 as it pursues an ambitious vertical integration strategy.

The Boston-based company's new medication, called Journavx, is being placed on a tier that means it might be costlier than ...

Investing.com -- Vertex Pharmaceuticals Inc (NASDAQ: VRTX ).’s newly approved non-opioid pain medication, Journavx, has been included in UnitedHealth Group Inc (NYSE: UNH ).’s coverage, according to ...

UnitedHealth secured a major win against the DOJ’s $2.1 billion Medicare fraud lawsuit. A special master reviewing the case ...